These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29035119)

  • 1. Response to letter to the editor from Elinder and Nordberg concerning Byber et al. 2016. Cadmium or cadmium compounds and chronic kidney disease in workers and the general population: a systematic review, Crit Rev Toxicol. 46(3):191-240. DOI: 0.3109/10408444.2015.1076375.
    Byber K; Lison D; Verougstraete V; Dressel H; Hotz P
    Crit Rev Toxicol; 2017 Nov; 47(10):902-903. PubMed ID: 29035119
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Byber et al. in Critical Reviews in Toxicology 2016;46:191-240.
    Elinder CG; Nordberg GF
    Crit Rev Toxicol; 2017 Nov; 47(10):900-901. PubMed ID: 29035126
    [No Abstract]   [Full Text] [Related]  

  • 3. Cadmium or cadmium compounds and chronic kidney disease in workers and the general population: a systematic review.
    Byber K; Lison D; Verougstraete V; Dressel H; Hotz P
    Crit Rev Toxicol; 2016; 46(3):191-240. PubMed ID: 26513605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heavy metal nephropathy: considerations for exposure analysis.
    Lunyera J; Smith SR
    Kidney Int; 2017 Sep; 92(3):548-550. PubMed ID: 28807262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to letter to the editor from Chappelle, Spence, and Tury concerning Wolf et al. 2016: Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water. 2016, Crit. Rev. Toxicol. Vol 46: 43-53.
    Wolf DC; Embry MR
    Crit Rev Toxicol; 2016 Nov; 46(10):913-914. PubMed ID: 27805461
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic kidney disease in Mexico and its relation with heavy metals].
    Chávez-Gómez NL; Cabello-López A; Gopar-Nieto R; Aguilar-Madrid G; Marin-López KS; Aceves-Valdez M; Jiménez-Ramírez C; Cruz-Angulo MC; Juárez-Pérez CA
    Rev Med Inst Mex Seguro Soc; 2017; 55(6):725-734. PubMed ID: 29190866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to Muge Akpinar-Elci Letter to Editor re. Pierce et al., Diacetyl and 2,3-pentanedione exposures associated with cigarette smoking: implications for risk assessment of food and flavoring workers, Crit. Rev. Toxicol. 44(5):420-435, 2014.
    Pierce JS; Abelmann A; Finley BL
    Crit Rev Toxicol; 2014 Aug; 44(7):640-1. PubMed ID: 25068493
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Murray M. Finkelstein, letter to the editor re Bernstein et al: Health risk of chrysotile revisited. Crit Rev Toxicol, 2013; 43(2): 154-183.
    Bernstein D; Dunnigan J; Hesterberg T; Brown R; Legaspi Velasco JA; Barrerao R; Hoskins J; Gibbs A
    Crit Rev Toxicol; 2013 Sep; 43(8):709-10. PubMed ID: 23985075
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Letter to the Editor submitted by Dr. Nick Chartres and Ms. Courtney Cooper: RE: A systematic review of adverse health effects associated with oral cadmium exposure, by Schaefer HR et al. Regul Toxicol Pharmacol. 2022; 134:105243.
    Schaefer HR; Flannery BM; Crosby LM; Jones-Dominic OE; Punzalan C; Middleton K
    Regul Toxicol Pharmacol; 2023 Jun; 141():105392. PubMed ID: 37087091
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the Editor re Bernstein et al: Health risk of chrysotile revisited. Crit Rev Toxicol, 2013; 43(2): 154-183.
    Finkelstein MM
    Crit Rev Toxicol; 2013 Sep; 43(8):707-8. PubMed ID: 23985074
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to Letter to the Editor from Drs. van Kesteren, Pronk, Heusinkveld, Luijten and Hakkert concerning Yamada et al. (2021): Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). Crit. Rev. Toxicol. Vol. 51: 373-394.
    Yamada T; Cohen SM; Lake BG
    Crit Rev Toxicol; 2022 May; 52(5):399-402. PubMed ID: 35971811
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gao et al. (2016): Change of urinary cadmium and renal tubular protein in female works after cessation of cadmium exposure : Response to the Letter to the Editor by Kawada (2016).
    Lin D
    Int Arch Occup Environ Health; 2017 Apr; 90(3):307. PubMed ID: 28083706
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective associations between environmental heavy metal exposure and renal outcomes in adults with chronic kidney disease.
    Tsai CC; Wu CL; Kor CT; Lian IB; Chang CH; Chang TH; Chang CC; Chiu PF
    Nephrology (Carlton); 2018 Sep; 23(9):830-836. PubMed ID: 28632927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Kidney Disease and Exposure to Nephrotoxic Metals.
    Orr SE; Bridges CC
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRP proteins as potential mediators of heavy metal resistance in zebrafish cells.
    Long Y; Li Q; Wang Y; Cui Z
    Comp Biochem Physiol C Toxicol Pharmacol; 2011 Apr; 153(3):310-7. PubMed ID: 21147257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different binding forms of cadmium--implications for distribution and toxicity.
    Nordberg GF; Nordberg M
    J UOEH; 1987 Mar; 9 Suppl():153-64. PubMed ID: 3299599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental heavy metal exposure and chronic kidney disease in the general population.
    Kim NH; Hyun YY; Lee KB; Chang Y; Ryu S; Oh KH; Ahn C
    J Korean Med Sci; 2015 Mar; 30(3):272-7. PubMed ID: 25729249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decline in kidney function with chromium exposure is exacerbated with co-exposure to lead and cadmium.
    Tsai TL; Kuo CC; Pan WH; Chung YT; Chen CY; Wu TN; Wang SL
    Kidney Int; 2017 Sep; 92(3):710-720. PubMed ID: 28506761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel urinary biomarkers and their association with urinary heavy metals in chronic kidney disease of unknown aetiology in Sri Lanka: a pilot study.
    Wanigasuriya K; Jayawardene I; Amarasiriwardena C; Wickremasinghe R
    Ceylon Med J; 2017 Dec; 62(4):210-217. PubMed ID: 29390596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.